Kikuchi, Taku http://orcid.org/0000-0002-3210-7756
Tsukada, Nobuhiro
Kunisada, Kodai
Matsumoto, Chiaki
Nomura-Yogo, Moe
Oda, Yuki
Sato, Kota
Takei, Tomomi
Ogura, Mizuki
Abe, Yu
Suzuki, Kenshi
Hosoya, Osamu
Ishida, Tadao
Article History
Received: 2 April 2024
Accepted: 4 June 2024
First Online: 6 June 2024
Declarations
:
: This study was approved by the JRCMC Institutional Review Board and was conducted under an abbreviated informed consent procedure and an opt-out consent principle. None of the participants requested to be excluded from the study.
: TK received personal fees from Janssen, Takeda, and Sanofi. NT received personal fees from Janssen and Sanofi. TI received honoraria from Ono, Takeda, Celgene/Bristol-Myers Squibb, and Janssen. KS received honoraria from Takeda, Celgene, Ono, Amgen, Novartis, Sanofi, BMS, AbbVie, and Janssen; consultancy fees from Takeda, Amgen, Janssen, and Celgene; and research funding from BMS, Celgene, and Amgen. The authors declare no competing financial interests related to this study.